Estée Lauder says Re-Nutriv regimen cuts perceived age in 12-week clinical study
Estee Lauder Companies Inc. Class A
Estee Lauder Companies Inc. Class A EL | 0.00 |
- Estée Lauder Companies reported peer-reviewed clinical results for Estée Lauder Re-Nutriv in Journal of Clinical and Aesthetic Dermatology on Apr 20, 2026.
- Multi-ethnic 12-week study found Re-Nutriv regimen reduced calculated perceived age, supporting visible age-reversal claims without disclosing technical measurements.
- Separate peer-reviewed paper introduced expert-validated facial age-assessment model built from more than 2,800 women across ethnicities, skin tones, age groups.
- Company positioned model as new benchmark for measuring visible age across diverse skin tones, strengthening clinical credentialing for future product performance claims.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Estée Lauder Companies Inc. published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.
